1. Early experience of maintenance durvalumab post chemoradiation (CRT) in stage III non-small cell lung cancer (NSCLC) across West Yorkshire network: from Expanded Access Programme (EAP) to routine clinical use. (January 2020) Authors: Jain, P.; Murray, P.; Clarke, K.; Franks, K.; Teo, M.; Saha, A.; Chan, S.; Conn, A.; Brown, N.; Rathbone, E. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment patterns in patients with advanced non-small cell lung cancer (aNSCLC): real-world data from the United Kingdom. (January 2020) Authors: Lester, J.; Khan, S.; Powell, C.; Escriu, C.; Hudson, E.; Conn, A.; Mansy, T.; Chan, S.; Brock, J.; Zhuo, X.; Durand, A.; Zhang, X.; Pawar, V. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗